CRISPR/Cas9 ADCY7 Knockout Stimulates the Insulin Secretion Pathway Leading to Excessive Insulin Secretion
AimDespite the enormous efforts to understand Congenital hyperinsulinism (CHI), up to 50% of the patients are genetically unexplained. We aimed to functionally characterize a novel candidate gene in CHI.PatientA 4-month-old boy presented severe hyperinsulinemic hypoglycemia. A routine CHI genetic pa...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.657873/full |
id |
doaj-97451878891041e0b24e1a12b02145b6 |
---|---|
record_format |
Article |
spelling |
doaj-97451878891041e0b24e1a12b02145b62021-06-11T16:45:24ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922021-06-011210.3389/fendo.2021.657873657873CRISPR/Cas9 ADCY7 Knockout Stimulates the Insulin Secretion Pathway Leading to Excessive Insulin SecretionYazeid Alhaidan0Yazeid Alhaidan1Yazeid Alhaidan2Yazeid Alhaidan3Henrik Thybo Christesen4Henrik Thybo Christesen5Henrik Thybo Christesen6Elena Lundberg7Mohammed A. Al Balwi8Mohammed A. Al Balwi9Mohammed A. Al Balwi10Klaus Brusgaard11Klaus Brusgaard12Klaus Brusgaard13Department of Clinical Genetics, Odense University Hospital, Odense, DenmarkDepartment of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, DenmarkDepartment of Medical Genomics Research, King Abdullah International Medical Research Center, Riyadh, Saudi ArabiaKing Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaDepartment of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, DenmarkHans Christian Andersen Children’s Hospital, Odense University Hospital, Odense, DenmarkOdense Pancreas Center, Odense, DenmarkInstitute of Clinical Science, Pediatrics, Umea University, Umeå, SwedenDepartment of Medical Genomics Research, King Abdullah International Medical Research Center, Riyadh, Saudi ArabiaKing Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaDepartment of Pathology and Laboratory Medicine, King Abdulaziz Medical City, NGHA, Riyadh, Saudi ArabiaDepartment of Clinical Genetics, Odense University Hospital, Odense, DenmarkDepartment of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, DenmarkNear East University, Nicosia, CyprusAimDespite the enormous efforts to understand Congenital hyperinsulinism (CHI), up to 50% of the patients are genetically unexplained. We aimed to functionally characterize a novel candidate gene in CHI.PatientA 4-month-old boy presented severe hyperinsulinemic hypoglycemia. A routine CHI genetic panel was negative.MethodsA trio-based whole-exome sequencing (WES) was performed. Gene knockout in the RIN-m cell line was established by CRISPR/Cas9. Gene expression was performed using real-time PCR.ResultsHyperinsulinemic hypoglycemia with diffuse beta-cell involvement was demonstrated in the patient, who was diazoxide-responsive. By WES, compound heterozygous variants were identified in the adenylyl cyclase 7, ADCY7 gene p.(Asp439Glu) and p.(Gly1045Arg). ADCY7 is calcium-sensitive, expressed in beta-cells and converts ATP to cAMP. The variants located in the cytoplasmic domains C1 and C2 in a highly conserved and functional amino acid region. RIN-m(-/-Adcy7) cells showed a significant increase in insulin secretion reaching 54% at low, and 49% at high glucose concentrations, compared to wild-type. In genetic expression analysis Adcy7 loss of function led to a 34.1-fold to 362.8-fold increase in mRNA levels of the insulin regulator genes Ins1 and Ins2 (p ≤ 0.0002), as well as increased glucose uptake and sensing indicated by higher mRNA levels of Scl2a2 and Gck via upregulation of Pdx1, and Foxa2 leading to the activation of the glucose stimulated-insulin secretion (GSIS) pathway.ConclusionThis study identified a novel candidate gene, ADCY7, to cause CHI via activation of the GSIS pathway.https://www.frontiersin.org/articles/10.3389/fendo.2021.657873/fullgeneticsmetabolomicscongenital hyperinsulinismhyperinsulinemic hypoglycemiapediatricsadenylyl cyclase |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yazeid Alhaidan Yazeid Alhaidan Yazeid Alhaidan Yazeid Alhaidan Henrik Thybo Christesen Henrik Thybo Christesen Henrik Thybo Christesen Elena Lundberg Mohammed A. Al Balwi Mohammed A. Al Balwi Mohammed A. Al Balwi Klaus Brusgaard Klaus Brusgaard Klaus Brusgaard |
spellingShingle |
Yazeid Alhaidan Yazeid Alhaidan Yazeid Alhaidan Yazeid Alhaidan Henrik Thybo Christesen Henrik Thybo Christesen Henrik Thybo Christesen Elena Lundberg Mohammed A. Al Balwi Mohammed A. Al Balwi Mohammed A. Al Balwi Klaus Brusgaard Klaus Brusgaard Klaus Brusgaard CRISPR/Cas9 ADCY7 Knockout Stimulates the Insulin Secretion Pathway Leading to Excessive Insulin Secretion Frontiers in Endocrinology genetics metabolomics congenital hyperinsulinism hyperinsulinemic hypoglycemia pediatrics adenylyl cyclase |
author_facet |
Yazeid Alhaidan Yazeid Alhaidan Yazeid Alhaidan Yazeid Alhaidan Henrik Thybo Christesen Henrik Thybo Christesen Henrik Thybo Christesen Elena Lundberg Mohammed A. Al Balwi Mohammed A. Al Balwi Mohammed A. Al Balwi Klaus Brusgaard Klaus Brusgaard Klaus Brusgaard |
author_sort |
Yazeid Alhaidan |
title |
CRISPR/Cas9 ADCY7 Knockout Stimulates the Insulin Secretion Pathway Leading to Excessive Insulin Secretion |
title_short |
CRISPR/Cas9 ADCY7 Knockout Stimulates the Insulin Secretion Pathway Leading to Excessive Insulin Secretion |
title_full |
CRISPR/Cas9 ADCY7 Knockout Stimulates the Insulin Secretion Pathway Leading to Excessive Insulin Secretion |
title_fullStr |
CRISPR/Cas9 ADCY7 Knockout Stimulates the Insulin Secretion Pathway Leading to Excessive Insulin Secretion |
title_full_unstemmed |
CRISPR/Cas9 ADCY7 Knockout Stimulates the Insulin Secretion Pathway Leading to Excessive Insulin Secretion |
title_sort |
crispr/cas9 adcy7 knockout stimulates the insulin secretion pathway leading to excessive insulin secretion |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Endocrinology |
issn |
1664-2392 |
publishDate |
2021-06-01 |
description |
AimDespite the enormous efforts to understand Congenital hyperinsulinism (CHI), up to 50% of the patients are genetically unexplained. We aimed to functionally characterize a novel candidate gene in CHI.PatientA 4-month-old boy presented severe hyperinsulinemic hypoglycemia. A routine CHI genetic panel was negative.MethodsA trio-based whole-exome sequencing (WES) was performed. Gene knockout in the RIN-m cell line was established by CRISPR/Cas9. Gene expression was performed using real-time PCR.ResultsHyperinsulinemic hypoglycemia with diffuse beta-cell involvement was demonstrated in the patient, who was diazoxide-responsive. By WES, compound heterozygous variants were identified in the adenylyl cyclase 7, ADCY7 gene p.(Asp439Glu) and p.(Gly1045Arg). ADCY7 is calcium-sensitive, expressed in beta-cells and converts ATP to cAMP. The variants located in the cytoplasmic domains C1 and C2 in a highly conserved and functional amino acid region. RIN-m(-/-Adcy7) cells showed a significant increase in insulin secretion reaching 54% at low, and 49% at high glucose concentrations, compared to wild-type. In genetic expression analysis Adcy7 loss of function led to a 34.1-fold to 362.8-fold increase in mRNA levels of the insulin regulator genes Ins1 and Ins2 (p ≤ 0.0002), as well as increased glucose uptake and sensing indicated by higher mRNA levels of Scl2a2 and Gck via upregulation of Pdx1, and Foxa2 leading to the activation of the glucose stimulated-insulin secretion (GSIS) pathway.ConclusionThis study identified a novel candidate gene, ADCY7, to cause CHI via activation of the GSIS pathway. |
topic |
genetics metabolomics congenital hyperinsulinism hyperinsulinemic hypoglycemia pediatrics adenylyl cyclase |
url |
https://www.frontiersin.org/articles/10.3389/fendo.2021.657873/full |
work_keys_str_mv |
AT yazeidalhaidan crisprcas9adcy7knockoutstimulatestheinsulinsecretionpathwayleadingtoexcessiveinsulinsecretion AT yazeidalhaidan crisprcas9adcy7knockoutstimulatestheinsulinsecretionpathwayleadingtoexcessiveinsulinsecretion AT yazeidalhaidan crisprcas9adcy7knockoutstimulatestheinsulinsecretionpathwayleadingtoexcessiveinsulinsecretion AT yazeidalhaidan crisprcas9adcy7knockoutstimulatestheinsulinsecretionpathwayleadingtoexcessiveinsulinsecretion AT henrikthybochristesen crisprcas9adcy7knockoutstimulatestheinsulinsecretionpathwayleadingtoexcessiveinsulinsecretion AT henrikthybochristesen crisprcas9adcy7knockoutstimulatestheinsulinsecretionpathwayleadingtoexcessiveinsulinsecretion AT henrikthybochristesen crisprcas9adcy7knockoutstimulatestheinsulinsecretionpathwayleadingtoexcessiveinsulinsecretion AT elenalundberg crisprcas9adcy7knockoutstimulatestheinsulinsecretionpathwayleadingtoexcessiveinsulinsecretion AT mohammedaalbalwi crisprcas9adcy7knockoutstimulatestheinsulinsecretionpathwayleadingtoexcessiveinsulinsecretion AT mohammedaalbalwi crisprcas9adcy7knockoutstimulatestheinsulinsecretionpathwayleadingtoexcessiveinsulinsecretion AT mohammedaalbalwi crisprcas9adcy7knockoutstimulatestheinsulinsecretionpathwayleadingtoexcessiveinsulinsecretion AT klausbrusgaard crisprcas9adcy7knockoutstimulatestheinsulinsecretionpathwayleadingtoexcessiveinsulinsecretion AT klausbrusgaard crisprcas9adcy7knockoutstimulatestheinsulinsecretionpathwayleadingtoexcessiveinsulinsecretion AT klausbrusgaard crisprcas9adcy7knockoutstimulatestheinsulinsecretionpathwayleadingtoexcessiveinsulinsecretion |
_version_ |
1721381891209166848 |